![]() |
Volumn 6, Issue 1, 2018, Pages 76-79
|
Acute Heart Failure Deserves a Log-Scale Boost in Research Support: Call for Multidisciplinary and Universal Actions
|
Author keywords
acute heart failure; chronic obstructive pulmonary disease; left ventricle ejection fraction; oral heart failure therapies
|
Indexed keywords
ANTIBIOTIC AGENT;
DIURETIC AGENT;
INOTROPIC AGENT;
SERELAXIN;
URODILATIN;
VASODILATOR AGENT;
ACUTE CORONARY SYNDROME;
ACUTE HEART FAILURE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL RESEARCH;
DRUG EFFICACY;
DRUG SAFETY;
HEALTH CARE FINANCING;
HEMODYNAMICS;
HUMAN;
LUNG EDEMA;
MORTALITY RISK;
NONHUMAN;
NONINVASIVE VENTILATION;
PATHOGENESIS;
PNEUMONIA;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
DRUG DEVELOPMENT;
HEART FAILURE;
HEART LEFT VENTRICLE FUNCTION;
HEART STROKE VOLUME;
DRUG DEVELOPMENT;
HEART FAILURE;
HUMANS;
STROKE VOLUME;
VENTRICULAR FUNCTION, LEFT;
|
EID: 85039945757
PISSN: 22131779
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jchf.2017.09.012 Document Type: Review |
Times cited : (15)
|
References (6)
|